Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 10;107(32):14327-32.
doi: 10.1073/pnas.1009536107. Epub 2010 Jul 26.

Myocytic androgen receptor controls the strength but not the mass of limb muscles

Affiliations

Myocytic androgen receptor controls the strength but not the mass of limb muscles

Céline Chambon et al. Proc Natl Acad Sci U S A. .

Abstract

The anabolic effects of androgens on skeletal muscles are thought to be mediated predominantly through the androgen receptor (AR), a member of the ligand-dependent nuclear receptor superfamily. However, despite numerous studies performed in men and in rodents, these effects remain poorly understood. To characterize androgen signaling in skeletal muscles, we generated mice in which the AR is selectively ablated in myofibers. We show that myocytic AR controls androgen-induced insulin-like growth factor IEa (IGF-IEa) expression in the highly androgen-sensitive perineal muscles and that it mediates androgen-stimulated postnatal hypertrophy of these muscles. In contrast, androgen-dependent postnatal hypertrophy of limb muscle fibers is independent of myocytic AR. Thus, androgens control perineal and limb muscle mass in male mice through myocytic AR-dependent and -independent pathways, respectively. Importantly, we also show that AR deficiency in limb myocytes impairs myofibrillar organization of sarcomeres and decreases muscle strength, thus demonstrating that myocytic AR controls key pathways required for maximum force production. These distinct androgen signaling pathways in perineal and limb muscles may allow the design of screens to identify selective androgen modulators of muscle strength.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Characterization of BC/LA muscles in ARskm-/y and AR(i)skm-/y mice. (A) BC/LA weight from 6- and 13-wk-old ARL2/y and ARskm-/y mice (n = 7). (B) Gross morphology of BC/LA (Upper) and histological analysis of H&E-stained BC muscle (Lower) of 13-wk-old ARL2/y and ARskm-/y mice. (Scale bar, 20 μm.) (C) Mean fiber CSA of BC muscle from 13-wk-old ARL2/y and ARskm-/y mice. (D and E) BC/LA weight from 8-wk-old (D) and 25-wk-old (E) ARL2/y and AR(i)skm-/y mice (n = 7). (F) BC/LA weight from 25-wk-old sham-operated (sham) and orchidectomized (Orx) ARL2/y mice, and from 25-wk-old ARskm-/y mice (n = 7). (G) IGF-IEa mRNA levels from 13-wk-old ARL2/y and ARskm-/y mice (n = 8). In A and CG, error bars indicate SEM; *, P < 0.05.
Fig. 2.
Fig. 2.
Characterization of hindlimb skeletal muscles in ARskm-/y mice and AR(i)skm-/y mice. (A) Gastrocnemius weight from 6- and 13-wk-old ARL2/y and ARskm-/y mice (n = 7). (B) Gross morphology of gastrocnemius (G) and soleus (S) muscles (Upper) and histological analysis of H&E-stained gastrocnemius muscle (Lower) from 13-wk-old ARL2/y and ARskm-/y mice. (Scale bar, 20 μm.) (C) Mean fiber CSA of gastrocnemius muscle from 13-wk-old ARL2/y and ARskm-/y mice. (D) Gastrocnemius weight from 12- and 32-wk-old ARL2/y and AR(i)skm-/y mice (n = 7). Gastrocnemius weight (E), mean fiber CSA (F), and IGF-IEa mRNA levels (G) from 25-wk-old sham-operated (sham) and orchidectomized (Orx) ARL2/y and ARskm-/y mice (n = 6). In A and CG, error bars indicate SEM. In A, F, and G, *P < 0.05. In G, #P ≥ 0.05.
Fig. 3.
Fig. 3.
Characterization of muscle contractile functions in ARskm-/y mice. (A) Maximal grip strength of ARL2/y and ARskm-/y mice between the ages of 6 and 65 wk (n = 8–10). (B) In situ absolute maximal isometric tetanic force of tibialis anterior muscle from 20-wk-old ARL2/y and ARskm-/y mice (n = 7–8). (C) In vitro absolute maximal isometric tetanic force of EDL and of soleus muscles from 20-wk-old ARL2/y and ARskm-/y mice (n = 7–8). In A–C, error bars indicate SEM; *P < 0.05. In C, #P = 0.84. (D) Ultrastructure of EDL muscle from 15-wk-old ARL2/y and ARskm-/y mice. Black arrowheads indicate Z line disruptions; white arrowheads indicate loss of myofilaments; white arrows indicate sarcoplasm. A, A band; I, I band; H. H band; M, M line; Mt, mitochondria; Tt, T-tubules; Z, Z line.
Fig. 4.
Fig. 4.
Schematic model of androgen signaling in perineal and limb skeletal muscles.

References

    1. Bhasin S, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab. 1997;82:407–413. - PubMed
    1. Katznelson L, et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab. 1996;81:4358–4365. - PubMed
    1. Brodsky IG, Balagopal P, Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men—a clinical research center study. J Clin Endocrinol Metab. 1996;81:3469–3475. - PubMed
    1. Wang C, et al. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men—a clinical research center study. J Clin Endocrinol Metab. 1996;81:3654–3662. - PubMed
    1. Wang C, et al. Testosterone Gel Study Group Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab. 2000;85:2839–2853. - PubMed

Publication types

LinkOut - more resources